HealthEquity, Inc. (NASDAQ:HQY – Get Rating) Director Ian Sacks sold 25,000 shares of the company's stock in a transaction dated Tuesday, September 20th. The shares were sold at an average price of $72.28, for a total transaction of $1,807,000.00. Following the completion of the transaction, the director now directly owns 126,570 shares of the company's stock, valued at $9,148,479.60. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
HealthEquity Price Performance
Shares of HealthEquity stock traded up $1.65 on Thursday, hitting $73.50. The company had a trading volume of 1,162,452 shares, compared to its average volume of 749,338. The business has a 50-day simple moving average of $62.70 and a 200-day simple moving average of $62.64. The company has a market cap of $6.21 billion, a PE ratio of -99.27, a PEG ratio of 4.25 and a beta of 0.90. HealthEquity, Inc. has a 52 week low of $36.81 and a 52 week high of $74.04.
Get HealthEquity alerts:HealthEquity (NASDAQ:HQY – Get Rating) last issued its earnings results on Tuesday, September 6th. The company reported $0.33 earnings per share for the quarter, hitting analysts' consensus estimates of $0.33. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. During the same quarter in the previous year, the business earned $0.21 earnings per share. On average, equities research analysts predict that HealthEquity, Inc. will post 0.69 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
HQY has been the subject of a number of analyst reports. KeyCorp initiated coverage on shares of HealthEquity in a research report on Thursday, September 15th. They issued an "overweight" rating and a $85.00 price objective for the company. Robert W. Baird upped their target price on shares of HealthEquity from $47.00 to $67.00 and gave the company a "neutral" rating in a research note on Wednesday, September 7th. SVB Leerink upped their target price on shares of HealthEquity from $67.00 to $76.00 and gave the company an "outperform" rating in a research note on Tuesday, June 7th. Wells Fargo & Company increased their price objective on shares of HealthEquity from $95.00 to $100.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 13th. Finally, The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research note on Tuesday, July 12th. They set a "sell" rating and a $59.00 price objective on the stock. Two analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $75.36.Institutional Investors Weigh In On HealthEquity
Several hedge funds have recently made changes to their positions in the company. Private Trust Co. NA purchased a new stake in HealthEquity in the 2nd quarter worth approximately $28,000. Assetmark Inc. lifted its position in HealthEquity by 387.1% in the 2nd quarter. Assetmark Inc. now owns 755 shares of the company's stock worth $46,000 after buying an additional 600 shares in the last quarter. Signaturefd LLC lifted its position in HealthEquity by 44.3% in the 1st quarter. Signaturefd LLC now owns 954 shares of the company's stock worth $64,000 after buying an additional 293 shares in the last quarter. Clearstead Advisors LLC bought a new position in shares of HealthEquity during the 1st quarter valued at $65,000. Finally, Eagle Bay Advisors LLC raised its holdings in shares of HealthEquity by 137.8% during the 2nd quarter. Eagle Bay Advisors LLC now owns 1,108 shares of the company's stock valued at $68,000 after purchasing an additional 642 shares in the last quarter. Hedge funds and other institutional investors own 99.43% of the company's stock.
HealthEquity Company Profile
(Get Rating)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Stories
- Get a free copy of the StockNews.com research report on HealthEquity (HQY)
- The Institutions Hold On To Darden Restaurants International
- What Steelcase's Earnings Say About the Return to the Office?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.